Key Takeaways
- The U.S. Department of Energy granted Preliminary Documented Safety Analysis approval for Oklo’s Aurora facility at Idaho National Laboratory.
- Shares advanced 5.4% to $56.92 during premarket hours Thursday, despite declining approximately 47% in the last half-year.
- Federal approval encompasses hazard evaluation, accident assessment, design protocols, and safety assurances for the Aurora-INL facility.
- The company participates in a government pilot initiative aiming to activate a minimum of three experimental reactors at federal laboratories before early July.
- Recent analyst activity shows four upward earnings revisions, with UBS maintaining a Neutral stance and Wedbush projecting Outperform with a $110 target.
Oklo achieved a significant regulatory milestone Thursday following the U.S. Department of Energy’s authorization of the Preliminary Documented Safety Analysis for its Aurora facility located at Idaho National Laboratory. Premarket trading saw shares surge 5.4% to reach $56.92 following the announcement.
The authorization originated from the DOE’s Idaho Operations Office and encompasses preliminary safety foundations for Aurora-INL, addressing hazard evaluation, accident scenarios, protective measures, and structural specifications.
Chief Executive Jacob DeWitte characterized the development as “an important milestone for Aurora-INL” and noted it “helps establish a foundation for future Aurora deployments.”
This authorization falls within the DOE’s Reactor Pilot Program, which establishes a regulatory pathway for constructing and operating next-generation nuclear facilities under federal jurisdiction.
Oklo secured selection for the initiative in 2025 among nearly a dozen participating organizations. The program operates under an accelerated schedule, targeting operational status for no fewer than three experimental reactors at federal laboratories before early July.
Earlier in the week, the DOE announced that a design from competing firm Antares Nuclear would become the first reactor achieving criticality before the July 4 deadline — a development worth monitoring considering the program’s competitive dynamics.
Aurora-INL: Project Details
Aurora-INL represents Oklo’s inaugural fast fission power installation. The facility operates using repurposed fuel sourced from the Experimental Breeder Reactor-II, which ceased operations in 1994 following policy modifications and congressional funding elimination.
Oklo secured authorization to utilize this repurposed fuel through a competitive DOE selection process initiated in 2019, coinciding with the company’s receipt of site utilization authorization at Idaho National Laboratory.
The Aurora facility is under construction adjacent to Oklo’s Aurora Fuel Fabrication Facility, also situated at Idaho National Laboratory. That complementary installation obtained DOE safety clearance in December 2025, marking the first approval under the DOE’s Fuel Line Pilot Program.
Oklo is additionally evaluating plutonium as an interim fuel alternative during the establishment of domestic high-assay low-enriched uranium supply infrastructure.
Corporate Developments
On June 4, Oklo finalized its purchase of ARMEC, a precision manufacturing and mechanical engineering enterprise headquartered in Oak Ridge, Tennessee. The transaction brought approximately 40 engineers and technical professionals into Oklo’s workforce.
The organization also conducted its 2026 annual shareholder assembly, during which three Class II board members received election to terms extending through 2029.
Notwithstanding Thursday’s premarket advancement, the equity has experienced a challenging period. OKLO concluded at $54.02 before the announcement, representing a nearly 48% decline across the preceding six months, with market capitalization standing at roughly $9.4 billion.
Analyst perspectives remain divided. UBS recently reduced its price objective to $55 while preserving a Neutral assessment, highlighting capital needs and implementation challenges. Wedbush retained its Outperform designation and $110 price projection, emphasizing Oklo’s operational framework as a strategic differentiator.
Four analysts have adjusted their earnings projections upward for the upcoming period, per InvestingPro information.
Oklo maintains its pursuit of NRC licensure to facilitate future commercial activities extending beyond the DOE pilot structure.
